Senior Director, Corporate Development

Join to apply for the Senior Director, Corporate Development role at Medison Pharma
.

At Medison, we offer hope to patients suffering from rare and severe diseases. Through strategic partnerships with best-in-class biotech companies, we commercialize innovative therapies across global markets. Our culture is rooted in care, agility, collaboration, and innovation, and we’re united by a shared purpose to make a meaningful difference. If you’re passionate about driving growth and delivering breakthrough innovation to patients, we invite you to be part of our journey.

• Lead Medison’s valuation, forecasting and structuring across all types of transactions, in collaboration with BD, Market Research and Corporate Strategy. Act as a Center of Excellence for all Valuation matters in the company.
• Identify, evaluate and execute key transactions: M&A, strategic partnerships and other transactions in support of Medison’s growth. Lead cross‑functional teams through diligence efforts, ensuring rigorous analysis and internal collaboration.
• Develop and maintain a robust pipeline of strategic opportunities, aligned with Medison’s long‑term objectives. Build and manage relationships with internal and external stakeholders, including investment banks and potential partners.
• Work in collaboration with Corporate Strategy and other functions to support the Company’s Long‑Range Plan, BOD‑related analyses and other financial assessments.
• Spearhead post‑deal analysis, insights and implementation of key learnings in BD practices.
• Serve as a key thought partner to the CBO and broader Executive Team, contributing to long‑term value creation.
• Mentor, manage and develop a high‑performing corporate development team, cultivating an environment of leadership, collaboration and excellence.
• Collaborate and lead the integration of corporate, scientific and commercial assessments into comprehensive deal analysis.
• Represent Medison externally at key industry conferences and with potential partners, serving as a visible ambassador for the company’s growth strategy.

• 10‑15 years experience in investment banking, management consulting, corporate/business development in the healthcare industry. Strong preference for pharma/biotech related experience.
• Demonstrated successful track record in leading and closing M&A and other transaction types. Commercial‑stage companies preferred. Ex‑US transaction experience preferred, but not mandatory.
• Extensive knowledge of M&A, financial analysis, valuation and deal structuring.
• Understanding of the drug development lifecycle and regulatory pathways.
• MBA or other advanced degree.
• Entrepreneurial mindset, highly driven, hands‑on, excited by fast‑paced hyper‑growth company.
• Excellent communication skills and ability to engage with C‑level executives.
• Inspirational leader, collaborative, builds trust and alignment across teams and seniority.

• The opportunity to make an impact at the enterprise level.
• A patient‑centric, mission‑driven culture that values collaboration, excellence and ownership.
• Competitive compensation and benefits package.

United States (Greater NY or Greater Boston preferred; remote position).

Chief Business Officer.

$225,000–$275,000 per annum. The successful candidate’s starting base pay will be determined based on job‑related skills, experience, qualifications, work location, and market conditions. The expected base pay range for this role may be modified based on market conditions.

Medison is committed to building a diverse and inclusive workplace. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability, or protected veteran status.